Fexostad 60

OTC

Indications:

The symptomatic relief of seasonal allergic rhinitis, chronic idiopathic urticarial in adults and children older than 6 years of age.

Dosage:

• Adults and children aged 12 years and over: 60 mg twice daily or 180 mg once daily.
• Children 6 – 12 years of age: 30 mg twice daily.
• Patients with impaired renal function or those on hemodialysis: Adults and children aged 12 years and over: 60 mg once daily.

Usage:

Fexostad 60 is administered orally and taken with or without food.

Known hypersensitivity to any ingredient in the formulation.

Common: Drowsiness, fatigue, headache, insomnia, dizziness. Nausea, indigestion. Virus infection (cold, flue), dysmenorrhea, upper respiratory tract infections, itchy throat, cough, fever, tympanitis, sinusitis, backache.

Uncommon: Dry mouth, stomachache. Fear, sleep disorders, nightmare.

• Monitoring renal function may be useful and dosage should be selected with caution in elderly patients.
• Fexofenadine has been associated with increased QTc interval, syncope, and ventricular arrhythmia in at least one susceptible patient with preexisting cardiovascular risk.
• Patients also should be advised not to use other antihistamines or decongestants for self-medication. If nervousness, dizziness, or sleepiness occurs during therapy, patients should be advised to discontinue use of the fixed-combination preparation and consult a clinician.
• Fexostad 60 should be used during pregnancy only when the potential benefits justify the possible risks to the fetus. Fexofenadine should be used with caution in nursing women, and a decision should be made whether to discontinue nursing or the drug.
• Patients should be aware of how they react to Fexostad 60 before driving or operating machinery.